%0 Generic
%T Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation
%A Kang, Yoon-Koo
%A Kang, Byung Woog
%A Im, Seock-Ah
%A Lee, Jae-Lyun
%A Park, Sook Ryun
%A Kang, Won Ki
%A Chang, Heung Moon
%A Kim, Tae Won
%A Oh, Do-Youn
%A Jung, Kyung Hae
%A Ryu, Min-Hee
%I Springer Science and Business Media LLC
%@ 0344-5704
%@ 1432-0843
%K Pharmacology (medical)
%K Cancer Research
%K Pharmacology
%K Toxicology
%K Oncology
%D 2013
%C Springer Science and Business Media LLC
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation